Key Concepts in Cardiovascular Secondary Prevention: A Case-Based Review

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is a leading global health issue, causing significant years of life lost.
• While aging is a primary risk factor, ASCVD incidence is increasing in younger populations due to rising hypertension and diabetes rates.
• Patients with ASCVD face a high risk of recurrent events, necessitating robust secondary prevention strategies.

Purpose of the Study:

• To review evidence-based pharmacological strategies for secondary prevention of ASCVD.
• To focus on practical clinical applications of key medications in ASCVD management.

Main Methods:

• This is a case-based review of existing literature.
• The review focuses on pharmacological interventions for secondary ASCVD prevention.

Main Results:

• Key drug classes discussed include antiplatelets, lipid-lowering therapies, antihypertensives, and glucose-lowering treatments.
• The review emphasizes the role of these medications in reducing ASCVD recurrence and mortality.

Conclusions:

• Aggressive pharmacological secondary prevention is crucial for managing ASCVD.
• Effective use of antiplatelets, lipid-lowering, antihypertensive, and glucose-lowering therapies can significantly improve outcomes for ASCVD patients.